Abstract Details
|
Helen Hochstetler, PharmD
(Lilly USA)
PRESENTER |
Helen Hochstetler, PharmD has received personal compensation for serving as an employee of Eli Lilly and Company. Helen Hochstetler, PharmD has received stock or an ownership interest from Eli Lilly and Company. |
| Teena Shetty, MD, FAAN (Hospital for Special Surgery) | Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL. |
| Paula Trzepacz, MD (Eli Lilly and Company) | No disclosure on file |
| Shufang Wang | No disclosure on file |
| No disclosure on file | |
| Michael G. Case, MS (Eli Lilly and Company) | Mr. Case has received personal compensation for serving as an employee of Eli Lilly and Company. Mr. Case has received stock or an ownership interest from Eli Lilly and Company. |
| No disclosure on file | |
| No disclosure on file | |
| Elisabeth Degenhardt | No disclosure on file |
| Constantine Lyketsos (Johns Hopkins Medicine) | Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care. |